Dosing of growth hormone in growth hormone deficiency

Hormone Research

Volumn 51, Issue SUPPL. 3, 1999, Pages 70-74

  Ranke, Michael B ^a   Schweizer, Roland ^a   Wollmann, Hartmut A ^a   Schwarze, Phillip ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

Growth hormone deficiency; Growth hormone therapy; Growth hormone, dosing, treatment design; Insulin like growth factor; Prediction algorithms

Indexed keywords

GROWTH HORMONE; RECOMBINANT GROWTH HORMONE; SOMATOMEDIN;

ALGORITHM; BODY HEIGHT; BODY SURFACE; BODY WEIGHT; CONFERENCE PAPER; DRUG EFFICACY; DRUG SAFETY; GROWTH HORMONE DEFICIENCY; GROWTH HORMONE RELEASE; HEALTH CARE COST; HUMAN; PREDICTION; PRIORITY JOURNAL; PUBERTY; REIMBURSEMENT; STANDARDIZATION; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0032722652     PISSN: 03010163     EISSN: None     Source Type: Journal    
DOI: 10.1159/000053165     Document Type: Conference Paper

References (40)

1. Raben MS: Treatment of a pituitary dwarf with human growth hormone. J Clin Endocrinol Metab 1958;18:901-903.
2. Veldhuis JD: New modalities for understanding dynamic regulation of the somatotropic (GH) axis: explication of gender differences in GH neuroregulation in the human. J Pediatr Endocrinol Metab 1996;9(suppl 3):237-253.
3. Baumann G, Mercado M: Growth hormone-binding protein in plasma. Nutrition 1993;9: 546-553.
4. Baumann G, Lowman HB, Mercado M, Wells JA: The stoichiometry of growth hormone-binding protein complexes in human plasma: comparison with cell surface receptors. J Clin Endocrinol Metab 1994;78:1113-1118.
5. Ranke MB, Elmlinger M: Functional role of insulin-like growth factor binding proteins. Horm Res 1997;48(supp1 4):9-15.
6. Green H, Morikawa M, Nixon T: A dual effector theory of growth hormone action. Differentiation 1985;19:195-198.
7. Ranke MB, Price DA, Albertsson-Wikland K, Maes M, Lindberg A, on behalf of the International Board of the Kabi Pharmacia International Growth Study: Factors determining pubertal growth and final height in growth hormone treatment of idiopathic growth hormone deficiency. Horm Res 1997;48:62-71.
8. Albertsson-Wikland K, Rosberg S, Libre E, Lundberg LO, Groth T: Growth hormone secretory rates in children as estimated by deconvolution analysis of 24-h plasma concentration profiles. Am J Physiol Endocrinol Metab 1989; 20(257):E809-E814.
9. Albertsson-Wikland K, Rosberg S, Karlberg J, Groth T: Analysis of 24-hour growth hormone profiles in healthy boys and girls of normal stature: relation to puberty. J Clin Endocrinol Metab 1994;78:1195-1201.
10. Martha PM Jr, Gorman KM, Blizzard RM, Rogol AD, Veldhuis JD: Endogenous growth hormone secretion and clearance rates in normal boys, as determined by deconvolution analysis: relationship to age, pubertal status and body mass. J Clin Endocrinol Metab 1992; 74:336-344.
11. Martha PM Jr, Rogol AD, Veldhuis JD, Kerrigan JR, Goodman DW, Blizzard RM: Alterations in the pulsatile properties of circulating growth hormone concentrations during puberty in boys. J Clin Endocrinol Metab 1989;69: 563-570.
12. Giustina A, Scalvini T. Tassi C, Desenzani P, Poiesi C, Wehrenberg WB, Rogol AD, Veldhuis JD: Maturation of the regulation of growth hormone secretion in young males with hypogonadotropic hypogonadism pharmacologically exposed to progressive increments in serum testosterone. J Clin Endocrinol Metab 1997;82:1210-1219.
13. Ho KY, Evans WS, Blizzard RM, Veldhuis JD, Merriam GR, Samojlik E, Furlanetto R, Rogol AD, Kaiser DL, Thorner MO: Effects of sex and age on the 24-hour profile of growth hormone secretion in man: importance of endogenous estradiol concentrations. J Clin Endocrinol Metab 1987;64:51-58.
14. Mauras N, Blizzard RM, Link K, Johnson ML, Rogol AD, Veldhuis JD: Augmentation of growth hormone secretion during puberty: evidence for a pulse amplitude-modulated phenomenon. J Clin Endocrinol Metab 1987;64: 596-601.
15. Rose SR, Municchi G, Barnes KM, Kamp GA, Uriarte MM, Ross JL, Cassorla F, Cutler GB Jr: Spontaneous growth hormone secretion increases during puberty in normal girls and boys. J Clin Endocrinol Metab 1991;73:428-435.
16. Zadik Z, Chalew SA, McCarter RJ Jr, Meistas M, Kowarski AA: The influence of age on the 24-hour integrated concentration of growth hormone in normal individuals. J Clin Endocrinol Metab 1985;60:513-516.
17. Juul A, Bang P, Hertel NT, Main K, Dalgaard P, Jørgensen K, Müller J, Hall K, Skakkebæk NE: Serum insulin-like growth factor-I in 1030 healthy children, adolescents, and adults: relation to age, sex, stage of puberty, testicular size, and body mass index. J Clin Endocrinol Metab 1994;78:744-752.
18. Wilson DM, Baker B, Hintz RL, Rosenfeld RG: Subcutaneous versus intramuscular growth hormone therapy: growth and acute somatomedin response. Pediatrics 1985;76:361-364.
19. Jørgensen JOL, Müller N, Lauritzen T, Alberti KGMM, Ørskov H, Christiansen JS: Evening versus morning injections of growth hormone (GH) in GH-deficient patients: effects on 24-hour patterns of circulating hormones and metabolites. J Clin Endocrinol Metab 1990;70: 207-214.
20. Milner RD, Russell-Fraser T, Brook CG, Cotes PM, Fraquhar JW, Parkin JM, Preece MA, Snodgrass GJ, Mason AS, Tanner JM, Vince FP: Experience with human growth hormone in Great Britain: the report of the MRC Working Party. Clin Endocrinol (Oxf) 1979;11:15-38.
21. Kastrup KW, Christiansen JS, Andersen JK, Ørskov H: Increased growth rate following transfer to daily sc administration from three weekly im injections of hGH in growth hormone deficient children. Acta Endocrinol 1983;104:148-152.
22. Albertsson-Wikland K, Westphal O, Westgren U: Daily subcutaneous administration of human growth hormone in growth hormone deficient children. Acta Pædiatr Scand 1986;75: 89-97.
23. McGillivray MH, Baptists J, Johanson A, on behalf of the Genentech Study Group: Outcome of a four-year randomized study of daily versus three times weekly somatotropin treatment in prepubertal naive growth hormone-deficient children. J Clin Endocrinol Metab 1996;81:1806-1809.
24. Jansson JO, Albertsson-Wikland K, Edén S, Thorngren KG, Isaksson O: Effect of frequency of growth hormone administration on longitudinal bone growth and body weight in hypophysectomized rats. Acta Physiol Scand 1982; 114:261-265.
25. Preece MA: Diagnosis and treatment of children with growth hormone deficiency. Clin Endocrinol Metab 1982;11:1-24.
26. Preece MA: Growth hormone deficiency - current problems. Eur J Pediatr 1979;132:215-219.
27. Grimberg A, Cohen P: Optimizing growth hormone therapy in children. Horm Res 1997; 48(suppl 5):11-15.
28. Link K, Blizzard RM, Evans WS, Kaiser DL, Parker MW, Rogol AD: The effect of androgens on the pulsatile release and the twenty-four-hour mean concentration of growth hormone in peripubertal males. J Clin Endocrinol Metab 1986;62:159-164.
29. Frasier SD, Costin G, Lippe BM, Aceto T Jr, Bunger PF: A dose-response curve for human growth hormone. J Clin Endocrinol Metab 1981;53:1213-1217.
30. Blethen SL, Compton P, Lippe BM, Rosenfeld RG, August GP, Johanson A: Factors predicting the response to growth hormone (GH) therapy in prepubertal children with GH deficiency. J Clin Endocrinol Metab 1993;76:574-579.
31. Ranke MB, Lindberg A, Chatelain P, Wilton P, Cutfield W, Albertsson-Wikland K, Price DA, on behalf of the KIGS International Board: Derivation and validation of a mathematical model for predicting the response to exogenous recombinant human growth hormone (GH) in prepubertal children with idiopathic GH deficiency. J Clin Endocrinol Metab 1999;84: 1174-1183.
32. Wit JM, Kamp GA, Rikken B: Spontaneous growth and response to growth hormone treatment in children with growth hormone deficiency and idiopathic short stature. Pediatr Res 1996;39:295-302.
33. Cutfield WS, Lindberg A, Chatelain P, Price DA, Albertsson-Wikland K, Wilton P, Ranke MB, on behalf of the KIGS International Board: Final height following growth hormone treatment of idiopathic growth hormone deficiency in KIGS; in Ranke MB, Wilton P (eds): Growth Hormone Therapy in KIGS - 10 Years' Experience. Heidelberg, Barth, 1999, pp 93-109.
34. Codner E, Mericq V, Cassorla F: Optimizing growth hormone therapy during puberty. Horm Res 1997;48(suppl 5): 16-20.
35. Blum WF: Insulin-like growth factors and IGF-binding proteins: their use for diagnosis of growth hormone deficiency; in Juul A, Jargensen JOL (eds): Growth Hormone in Adults: Physiological and Clinical Aspects. Cambridge, Cambridge University Press, 1996, pp 48-74.
36. de Boer H, Blok GJ, Popp-Snijders C, Stuurman L, Baxter RC, van der Veen E: Monitoring of growth hormone replacement therapy in adults, based on measurement of serum markers. J Clin Endocrinol Metab 1996;81:1371-1377.
37. Burns EC, Tanner JM, Preece MA, Cameron N: Final height and pubertal development in 55 children with idiopathic growth hormone deficiency, treated for between 2 and 15 years with human growth hormone. Eur J Pediatr 1981;137:155-164.
38. Hibi I, Tanaka T, Tanae A, Kagawa J, Hashimoto N, Yoshizawa A, Shizume K: The influence of gonadal function and the effect of gonadal suppression treatment on final height in growth hormone (GH)-treated GH-deficient children. J Clin Endocrinol Metab 1989;69: 221-226.
39. Ranke MB, Guilbaud O, Lindberg A, Cole T: Prediction of the growth response in children with various growth disorders treated with growth hormone. Analysis of data from the Kabi Pharmacia International Growth Study. Acta Paediatr 1993;391(suppl):82-88.
40. Ranke MB, Schwarze CP, Mohnike K, von Mühlendahl KE, Keller E, Willgerodt H, Kiess W: Catch-up growth after childhood-onset substitution in hypothyroidism: Is it a guide towards optimal growth hormone treatment in idiopathic growth hormone deficiency? Horm Res 1998;50:264-270.